Kent Wakeford Overview
- Investor Type
-
Angel
- Investments
-
7
- Portfolio
-
5
- Exits
-
2
Kent Wakeford General Information
Description
Mr. Kent Wakeford serves as Co-CEO at Form Bio. Mr. Wakeford is also a Co-Founder & serves as Executive Chairman at Breaking. Mr. Wakeford is a Co-Founder & serves as Board Member at tvScientific. He is a Co-Founder & serves as Special Executive Advisor To The CEO at Colossal Laboratories & Biosciences. He serves as Board Member at FanAI. He served as Chief Operating Officer at Aftershock Services. He serves as an Advisor at Parade Ventures. He co-founded and served as Chief Operating Officer Forte (Software Development Applications). He co-founded & served as & Co-Vice Chairman Gen.G. He began his digital career at Netscape and spent more than five years at AOL as a Vice President, facilitating more than 250 partnerships across AOL web properties as well as Time Inc., Turner, and Warner Bros. Prior to joining Kabam, he was SVP at AddThis social sharing platform and co-founded the media valuation Head verification company Integral Ad Science. He holds an JD from University of Southern California (USC) & also holds an BA degree from University of California, Los Angeles (UCLA).
Business Details
Primary Investor Type
Corporate Office
- 1401 Lavaca Street
- Unit number 155
- Austin, TX 78701
- United States
Kent Wakeford Investments (7)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Tatsumeeko | 01-Aug-2022 | Later Stage VC | 0000 | Entertainment Software | Generating Revenue | 0000 0000000 |
Oooh | 14-May-2021 | 00000 00000 | 000.00 | Social/Platform Software | Generating Revenue | 0000 0000000 |
Now Do | 31-Mar-2021 | 0000 00000 | 00.000 | Educational Software | Generating Revenue | 0000 0000000 |
Carbonated | 16-Jul-2020 | 0000 00000 | 0000 | Entertainment Software | Generating Revenue | 0000 0000000 |
Brainbase | 11-May-2020 | 00000 00000 | 000 | Business/Productivity Software | Generating Revenue | 0000 0000000 |
Samsara Therapeutics | 20-Dec-2019 | Seed Round | 00.00 | Drug Discovery | Pre-Clinical Trials | 0000 0000000 |
Enjoius | 29-Nov-2017 | Seed Round | 00.00 | Internet Retail | Out of Business | 0000 0000000 |
Kent Wakeford Exits (2)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Brainbase | 16-Sep-2022 | Merger/Acquisition | |
Enjoius | 14-Jan-2019 | 000 00 00000 |
Kent Wakeford Investments by Industry, Year, and Region
Kent Wakeford Team (1)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Kent Wakeford JD | Angel Investor | 0 | 0 | Austin, TX |
Kent Wakeford Co-Investors (75)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Andreessen Horowitz | 1 | 0 | |||
Bessemer Venture Partners | 0 | 0 | 0 | ||
Golden Ventures | 0 | 0 | |||
Khosla Ventures | 0 | 0 | |||
Unity Software | 0 | 0 |
Kent Wakeford FAQs
-
Who is Kent Wakeford?
Kent Wakeford is an angel Investor who has made 7 investments.
-
What kind of investor is Kent Wakeford?
Kent Wakeford is an angel investor.
-
What does Kent Wakeford do?
As an angel investor, Kent Wakeford invests personal money into promising companies, typically in exchange for equity.
-
How many board seats does Kent Wakeford hold?
Kent Wakeford holds 2 board seats including Skillz and FanAI.
-
What has Kent Wakeford invested in?
Kent Wakeford has made numerous investments in companies like Tatsumeeko, Oooh, and Now Do within the Entertainment Software, Social/Platform Software, and Educational Software industries.
-
What has Kent Wakeford invested in recently?
Kent Wakeford's latest investment was on 01-Aug-2022 in Tatsumeeko, a company within the Entertainment Software industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »